[Long-term results in patients with pulmonary tuberculosis treated with specific chemical and antibiotic drugs and bearers of Koch bacilli resistant to these].
D000818:Animals; D000900:Anti-Bacterial Agents; D009169:Mycobacterium tuberculosis; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000628:therapy*; D001503:Ursidae
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D009525:Niacin; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy
Il destino a distanza dei pazienti affetti da tubercolosi polmonare trattati con chemio-antibiotici specifici e portatori di bacilli di Koch a questi resistenti.